Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE

Active, not recruitingOBSERVATIONAL
Enrollment

2,870

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

April 30, 2025

Conditions
Valvular Heart Disease
Trial Locations (1)

94596

Hawthorne Effect, Walnut Creek

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CVS Caremark

INDUSTRY

collaborator

Hawthorne Effect Inc.

OTHER

collaborator

Columbia University

OTHER

collaborator

Vanderbilt University Medical Center

OTHER

collaborator

University of Michigan

OTHER

collaborator

Walgreens

INDUSTRY

lead

Cardiovascular Research Foundation, New York

OTHER